Tower Research Capital LLC TRC increased its position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 1,130.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17…